Train transfers for COVID ICU patients: did it work?
NCT ID NCT04433325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 37 critically ill COVID-19 patients who were moved by train from overcrowded ICUs in Paris to less busy ICUs in western France. Researchers tracked how many died, got infections, needed breathing machines, and how long they stayed in the hospital. The goal was to learn from this large-scale medical evacuation to improve future emergency responses.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help improve emergency patient transport plans for future health crises.
- What could go wrong
- This is a small, completed observational study with only 37 patients. It does not test a treatment, so it cannot directly lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
37 people
The number who actually took part.
- Started
-
Jul 2020
- Finished
-
Oct 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
COVID-19 positive patients admitted in Intensive Care Unit between 15/03/2020 and 15/04/2020
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 years * COVID-19 positive patients admitted in Intensive Care Unit between 15/03/2020 and 15/04/2020 * Patients (or legal representative) with no opposition to inclusion in medical research protocol * Regarding case group : Patients transferred from Paris's ICU * Regarding case control group : Patients admitted in ICU with no transfer from Paris Exclusion Criteria: \- \> 18 years under legal protection and patients with liberty restriction
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID -19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Poitiers
Poitiers, France
-
CHU Tours
Tours, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- Can lung ultrasound reveal COVID-19's signature in the lungs?
- When the immune system Can't fight back: tracking three respiratory viruses
- The household maze: how does COVID-19 move between family members?
- Can a stress course lighten the load on ICU families?
- Can an oral drug stop COVID-19 from turning deadly?